COVID-19 Impact on Global Retinal Disorder Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 91 pages | ID: C102CDA9B43AEN
QYResearch

Abstracts

This report focuses on the global Retinal Disorder Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Retinal Disorder Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Santen Pharmaceutical
• REGENERON
• Graybug Vision
• Takeda Pharmaceuticals
• Bayer
• Roche-Genentech
• Acucela
• Pfizer

Market segment by Type, the product can be split into

• Gels
• Capsules & Tablets
• Eye Drops
• Ointments

Market segment by Application, split into

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Retinal Disorder Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Retinal Disorder Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Retinal Disorder Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Retinal Disorder Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Retinal Disorder Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Gels
  1.4.3 Capsules & Tablets
  1.4.4 Eye Drops
  1.4.5 Ointments
1.5 Market by Application
  1.5.1 Global Retinal Disorder Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacy
  1.5.3 Online Pharmacy
  1.5.4 Retail Pharmacy
1.6 Coronavirus Disease 2019 (Covid-19): Retinal Disorder Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Retinal Disorder Treatment Industry
    1.6.1.1 Retinal Disorder Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Retinal Disorder Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Retinal Disorder Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Retinal Disorder Treatment Market Perspective (2015-2026)
2.2 Retinal Disorder Treatment Growth Trends by Regions
  2.2.1 Retinal Disorder Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Retinal Disorder Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Retinal Disorder Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Retinal Disorder Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Retinal Disorder Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Retinal Disorder Treatment Players by Market Size
  3.1.1 Global Top Retinal Disorder Treatment Players by Revenue (2015-2020)
  3.1.2 Global Retinal Disorder Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Retinal Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Retinal Disorder Treatment Market Concentration Ratio
  3.2.1 Global Retinal Disorder Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Retinal Disorder Treatment Revenue in 2019
3.3 Retinal Disorder Treatment Key Players Head office and Area Served
3.4 Key Players Retinal Disorder Treatment Product Solution and Service
3.5 Date of Enter into Retinal Disorder Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Retinal Disorder Treatment Historic Market Size by Type (2015-2020)
4.2 Global Retinal Disorder Treatment Forecasted Market Size by Type (2021-2026)

5 RETINAL DISORDER TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Retinal Disorder Treatment Market Size by Application (2015-2020)
5.2 Global Retinal Disorder Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Retinal Disorder Treatment Market Size (2015-2020)
6.2 Retinal Disorder Treatment Key Players in North America (2019-2020)
6.3 North America Retinal Disorder Treatment Market Size by Type (2015-2020)
6.4 North America Retinal Disorder Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Retinal Disorder Treatment Market Size (2015-2020)
7.2 Retinal Disorder Treatment Key Players in Europe (2019-2020)
7.3 Europe Retinal Disorder Treatment Market Size by Type (2015-2020)
7.4 Europe Retinal Disorder Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Retinal Disorder Treatment Market Size (2015-2020)
8.2 Retinal Disorder Treatment Key Players in China (2019-2020)
8.3 China Retinal Disorder Treatment Market Size by Type (2015-2020)
8.4 China Retinal Disorder Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Retinal Disorder Treatment Market Size (2015-2020)
9.2 Retinal Disorder Treatment Key Players in Japan (2019-2020)
9.3 Japan Retinal Disorder Treatment Market Size by Type (2015-2020)
9.4 Japan Retinal Disorder Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Retinal Disorder Treatment Market Size (2015-2020)
10.2 Retinal Disorder Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Retinal Disorder Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Retinal Disorder Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Retinal Disorder Treatment Market Size (2015-2020)
11.2 Retinal Disorder Treatment Key Players in India (2019-2020)
11.3 India Retinal Disorder Treatment Market Size by Type (2015-2020)
11.4 India Retinal Disorder Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Retinal Disorder Treatment Market Size (2015-2020)
12.2 Retinal Disorder Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Retinal Disorder Treatment Market Size by Type (2015-2020)
12.4 Central & South America Retinal Disorder Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Santen Pharmaceutical
  13.1.1 Santen Pharmaceutical Company Details
  13.1.2 Santen Pharmaceutical Business Overview and Its Total Revenue
  13.1.3 Santen Pharmaceutical Retinal Disorder Treatment Introduction
  13.1.4 Santen Pharmaceutical Revenue in Retinal Disorder Treatment Business (2015-2020))
  13.1.5 Santen Pharmaceutical Recent Development
13.2 REGENERON
  13.2.1 REGENERON Company Details
  13.2.2 REGENERON Business Overview and Its Total Revenue
  13.2.3 REGENERON Retinal Disorder Treatment Introduction
  13.2.4 REGENERON Revenue in Retinal Disorder Treatment Business (2015-2020)
  13.2.5 REGENERON Recent Development
13.3 Graybug Vision
  13.3.1 Graybug Vision Company Details
  13.3.2 Graybug Vision Business Overview and Its Total Revenue
  13.3.3 Graybug Vision Retinal Disorder Treatment Introduction
  13.3.4 Graybug Vision Revenue in Retinal Disorder Treatment Business (2015-2020)
  13.3.5 Graybug Vision Recent Development
13.4 Takeda Pharmaceuticals
  13.4.1 Takeda Pharmaceuticals Company Details
  13.4.2 Takeda Pharmaceuticals Business Overview and Its Total Revenue
  13.4.3 Takeda Pharmaceuticals Retinal Disorder Treatment Introduction
  13.4.4 Takeda Pharmaceuticals Revenue in Retinal Disorder Treatment Business (2015-2020)
  13.4.5 Takeda Pharmaceuticals Recent Development
13.5 Bayer
  13.5.1 Bayer Company Details
  13.5.2 Bayer Business Overview and Its Total Revenue
  13.5.3 Bayer Retinal Disorder Treatment Introduction
  13.5.4 Bayer Revenue in Retinal Disorder Treatment Business (2015-2020)
  13.5.5 Bayer Recent Development
13.6 Roche-Genentech
  13.6.1 Roche-Genentech Company Details
  13.6.2 Roche-Genentech Business Overview and Its Total Revenue
  13.6.3 Roche-Genentech Retinal Disorder Treatment Introduction
  13.6.4 Roche-Genentech Revenue in Retinal Disorder Treatment Business (2015-2020)
  13.6.5 Roche-Genentech Recent Development
13.7 Acucela
  13.7.1 Acucela Company Details
  13.7.2 Acucela Business Overview and Its Total Revenue
  13.7.3 Acucela Retinal Disorder Treatment Introduction
  13.7.4 Acucela Revenue in Retinal Disorder Treatment Business (2015-2020)
  13.7.5 Acucela Recent Development
13.8 Pfizer
  13.8.1 Pfizer Company Details
  13.8.2 Pfizer Business Overview and Its Total Revenue
  13.8.3 Pfizer Retinal Disorder Treatment Introduction
  13.8.4 Pfizer Revenue in Retinal Disorder Treatment Business (2015-2020)
  13.8.5 Pfizer Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Retinal Disorder Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Retinal Disorder Treatment Revenue
Table 3. Ranking of Global Top Retinal Disorder Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Retinal Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Gels
Table 6. Key Players of Capsules & Tablets
Table 7. Key Players of Eye Drops
Table 8. Key Players of Ointments
Table 9. COVID-19 Impact Global Market: (Four Retinal Disorder Treatment Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Retinal Disorder Treatment Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Retinal Disorder Treatment Players to Combat Covid-19 Impact
Table 14. Global Retinal Disorder Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Retinal Disorder Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Retinal Disorder Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Retinal Disorder Treatment Market Share by Regions (2015-2020)
Table 18. Global Retinal Disorder Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Retinal Disorder Treatment Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Retinal Disorder Treatment Market Growth Strategy
Table 24. Main Points Interviewed from Key Retinal Disorder Treatment Players
Table 25. Global Retinal Disorder Treatment Revenue by Players (2015-2020) (Million US$)
Table 26. Global Retinal Disorder Treatment Market Share by Players (2015-2020)
Table 27. Global Top Retinal Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Disorder Treatment as of 2019)
Table 28. Global Retinal Disorder Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Retinal Disorder Treatment Product Solution and Service
Table 31. Date of Enter into Retinal Disorder Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Retinal Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 34. Global Retinal Disorder Treatment Market Size Share by Type (2015-2020)
Table 35. Global Retinal Disorder Treatment Revenue Market Share by Type (2021-2026)
Table 36. Global Retinal Disorder Treatment Market Size Share by Application (2015-2020)
Table 37. Global Retinal Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. Global Retinal Disorder Treatment Market Size Share by Application (2021-2026)
Table 39. North America Key Players Retinal Disorder Treatment Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Retinal Disorder Treatment Market Share (2019-2020)
Table 41. North America Retinal Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. North America Retinal Disorder Treatment Market Share by Type (2015-2020)
Table 43. North America Retinal Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. North America Retinal Disorder Treatment Market Share by Application (2015-2020)
Table 45. Europe Key Players Retinal Disorder Treatment Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Retinal Disorder Treatment Market Share (2019-2020)
Table 47. Europe Retinal Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Retinal Disorder Treatment Market Share by Type (2015-2020)
Table 49. Europe Retinal Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Retinal Disorder Treatment Market Share by Application (2015-2020)
Table 51. China Key Players Retinal Disorder Treatment Revenue (2019-2020) (Million US$)
Table 52. China Key Players Retinal Disorder Treatment Market Share (2019-2020)
Table 53. China Retinal Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. China Retinal Disorder Treatment Market Share by Type (2015-2020)
Table 55. China Retinal Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. China Retinal Disorder Treatment Market Share by Application (2015-2020)
Table 57. Japan Key Players Retinal Disorder Treatment Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Retinal Disorder Treatment Market Share (2019-2020)
Table 59. Japan Retinal Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Retinal Disorder Treatment Market Share by Type (2015-2020)
Table 61. Japan Retinal Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Retinal Disorder Treatment Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Retinal Disorder Treatment Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Retinal Disorder Treatment Market Share (2019-2020)
Table 65. Southeast Asia Retinal Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Retinal Disorder Treatment Market Share by Type (2015-2020)
Table 67. Southeast Asia Retinal Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Retinal Disorder Treatment Market Share by Application (2015-2020)
Table 69. India Key Players Retinal Disorder Treatment Revenue (2019-2020) (Million US$)
Table 70. India Key Players Retinal Disorder Treatment Market Share (2019-2020)
Table 71. India Retinal Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. India Retinal Disorder Treatment Market Share by Type (2015-2020)
Table 73. India Retinal Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. India Retinal Disorder Treatment Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Retinal Disorder Treatment Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Retinal Disorder Treatment Market Share (2019-2020)
Table 77. Central & South America Retinal Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Retinal Disorder Treatment Market Share by Type (2015-2020)
Table 79. Central & South America Retinal Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Retinal Disorder Treatment Market Share by Application (2015-2020)
Table 81. Santen Pharmaceutical Company Details
Table 82. Santen Pharmaceutical Business Overview
Table 83. Santen Pharmaceutical Product
Table 84. Santen Pharmaceutical Revenue in Retinal Disorder Treatment Business (2015-2020) (Million US$)
Table 85. Santen Pharmaceutical Recent Development
Table 86. REGENERON Company Details
Table 87. REGENERON Business Overview
Table 88. REGENERON Product
Table 89. REGENERON Revenue in Retinal Disorder Treatment Business (2015-2020) (Million US$)
Table 90. REGENERON Recent Development
Table 91. Graybug Vision Company Details
Table 92. Graybug Vision Business Overview
Table 93. Graybug Vision Product
Table 94. Graybug Vision Revenue in Retinal Disorder Treatment Business (2015-2020) (Million US$)
Table 95. Graybug Vision Recent Development
Table 96. Takeda Pharmaceuticals Company Details
Table 97. Takeda Pharmaceuticals Business Overview
Table 98. Takeda Pharmaceuticals Product
Table 99. Takeda Pharmaceuticals Revenue in Retinal Disorder Treatment Business (2015-2020) (Million US$)
Table 100. Takeda Pharmaceuticals Recent Development
Table 101. Bayer Company Details
Table 102. Bayer Business Overview
Table 103. Bayer Product
Table 104. Bayer Revenue in Retinal Disorder Treatment Business (2015-2020) (Million US$)
Table 105. Bayer Recent Development
Table 106. Roche-Genentech Company Details
Table 107. Roche-Genentech Business Overview
Table 108. Roche-Genentech Product
Table 109. Roche-Genentech Revenue in Retinal Disorder Treatment Business (2015-2020) (Million US$)
Table 110. Roche-Genentech Recent Development
Table 111. Acucela Company Details
Table 112. Acucela Business Overview
Table 113. Acucela Product
Table 114. Acucela Revenue in Retinal Disorder Treatment Business (2015-2020) (Million US$)
Table 115. Acucela Recent Development
Table 116. Pfizer Business Overview
Table 117. Pfizer Product
Table 118. Pfizer Company Details
Table 119. Pfizer Revenue in Retinal Disorder Treatment Business (2015-2020) (Million US$)
Table 120. Pfizer Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Retinal Disorder Treatment Market Share by Type: 2020 VS 2026
Figure 2. Gels Features
Figure 3. Capsules & Tablets Features
Figure 4. Eye Drops Features
Figure 5. Ointments Features
Figure 6. Global Retinal Disorder Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Online Pharmacy Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Retinal Disorder Treatment Report Years Considered
Figure 11. Global Retinal Disorder Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Retinal Disorder Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Retinal Disorder Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Retinal Disorder Treatment Market Share by Players in 2019
Figure 16. Global Top Retinal Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Disorder Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Retinal Disorder Treatment Revenue in 2019
Figure 18. North America Retinal Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Retinal Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Retinal Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Retinal Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Retinal Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Retinal Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Retinal Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Santen Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Santen Pharmaceutical Revenue Growth Rate in Retinal Disorder Treatment Business (2015-2020)
Figure 27. REGENERON Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. REGENERON Revenue Growth Rate in Retinal Disorder Treatment Business (2015-2020)
Figure 29. Graybug Vision Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Graybug Vision Revenue Growth Rate in Retinal Disorder Treatment Business (2015-2020)
Figure 31. Takeda Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Takeda Pharmaceuticals Revenue Growth Rate in Retinal Disorder Treatment Business (2015-2020)
Figure 33. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Bayer Revenue Growth Rate in Retinal Disorder Treatment Business (2015-2020)
Figure 35. Roche-Genentech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Roche-Genentech Revenue Growth Rate in Retinal Disorder Treatment Business (2015-2020)
Figure 37. Acucela Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Acucela Revenue Growth Rate in Retinal Disorder Treatment Business (2015-2020)
Figure 39. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Pfizer Revenue Growth Rate in Retinal Disorder Treatment Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed